Brominated flame retardants: UQCRC1 and NR3C2 as potential targets in IBD and CRC
Food and Chemical Toxicology · 2026-10 · 216 · 116230
DOI: 10.1016/j.fct.2026.116230 ↗Kurz gefasst
Fachartikel in der Zeitschrift Food and Chemical Toxicology, 2026-10. Verfasst von Jianhai Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endoscopy Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361000, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Flame Retardants, Inflammatory Bowel Diseases, Hydrocarbons, Brominated. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Brominated flame retardants (BFRs) are persistent pollutants with health concerns, yet their molecular mechanisms in the inflammatory bowel disease (IBD) and colorectal cancer (CRC) are unclear. METHODS: We employed an integrated approach combining computational toxicology, bioinformatics, and molecular docking to identify core molecular targets linking BFR exposure to IBD/CRC. The prognostic and immunological significance of key genes was validated using TCGA data and functional assays in human CRC (HT29) and normal colon epithelial (NCM460) cells. RESULTS: We identified 12 core targets, notably UQCRC1 and NR3C2, which stably bind BFRs. Low expression of UQCRC1 and NR3C2 predicted poor patient prognosis and exhibited consistent positive correlations with anti-tumor immune cell infiltration. In vitro experiments demonstrated that BFR (TBBPA and HBCD) exposure markedly promoted the proliferation, viability and cell cycle progression of HT29 CRC cells, accompanied by significant downregulation of UQCRC1 and NR3C2 expression. In normal NCM460 colon epithelial cells, BFR treatment induced cytotoxicity, inhibited cell proliferation, triggered the upregulation of pro-inflammatory cytokines, and disrupted intestinal barrier function by suppressing the expression of intestinal tight junction proteins. CONCLUSION: BFR exposure was accompanied by altered expression of UQCRC1/NR3C2 and phenotypic changes in colon cells. Dysregulation of the two genes was significantly correlated with clinical prognosis and tumor immune microenvironment in IBD and CRC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endoscopy Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361000, China.
- Department of Gastrointestinal Surgery, Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University, Changzhou Medical Center, Nanjing Medical University, No.68 Gehu Road, Wujin District, Changzhou, Jiangs…
- Department of Rehabilitation Medicine, The Third Hospital of Xiamen, Xiamen, 361015, China.
- Department of Gastrointestinal Oncology Surgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361000, China.
Zitieren
APA
Wu, J., Li, H., Wu, C., Wu, Y., Yu, H., & Chen, Z. (2026). Brominated flame retardants: UQCRC1 and NR3C2 as potential targets in IBD and CRC. Food and Chemical Toxicology, 216, 116230. https://doi.org/10.1016/j.fct.2026.116230
Vancouver
Wu J, Li H, Wu C, Wu Y, Yu H, Chen Z. Brominated flame retardants: UQCRC1 and NR3C2 as potential targets in IBD and CRC. Food and Chemical Toxicology. 2026;216:116230. doi:10.1016/j.fct.2026.116230
BibTeX
@article{Wu2026,
author = {Wu, Jianhai and Li, Haoran and Wu, Chongying and Wu, Yunzi and Yu, Huangdao and Chen, Zhigang},
title = {Brominated flame retardants: UQCRC1 and NR3C2 as potential targets in IBD and CRC},
journal = {Food and Chemical Toxicology},
year = {2026},
volume = {216},
pages = {116230},
doi = {10.1016/j.fct.2026.116230}
}
EUVIMED